These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

45 related items for PubMed ID: 1778315

  • 1. Further evaluation of the pertussis component vaccine produced by apoceruloplasmin affinity chromatography.
    Ginnaga A, Morokuma K, Furukawa S, Shigaki T, Katsuki N, Aihara K, Oka T, Sakoh M, Tamura C, Imaizumi A.
    Dev Biol Stand; 1991; 73():233-41. PubMed ID: 1778315
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
    Morokuma K, Ginnaga A, Nishihara T, Tsunoda S, Furukawa M, Aihara K, Sakoh M.
    Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers.
    Sato Y, Sato H.
    Tokai J Exp Clin Med; 1988; 13 Suppl():79-88. PubMed ID: 2908530
    [Abstract] [Full Text] [Related]

  • 6. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB.
    Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A novel bivalent acellular pertussis vaccine based on the 69 kDa protein and FHA.
    Novotny P, Chubb AP, Cownley K, Charles IG.
    Dev Biol Stand; 1991 Mar; 73():243-9. PubMed ID: 1778316
    [Abstract] [Full Text] [Related]

  • 10. Comparison of toxicities of acellular pertussis vaccine with whole cell pertussis vaccine in experimental animals.
    Sato Y, Sato H.
    Dev Biol Stand; 1991 Mar; 73():251-62. PubMed ID: 1778317
    [Abstract] [Full Text] [Related]

  • 11. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
    Vuolo AM, Lustigman B.
    Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
    [Abstract] [Full Text] [Related]

  • 12. Production and purification of Bordetella pertussis toxin.
    Ju CL, Sheu GC, Cheng Y, Lu CH.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 May; 30(2):72-83. PubMed ID: 10592813
    [Abstract] [Full Text] [Related]

  • 13. Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection.
    Alonso S, Pethe K, Mielcarek N, Raze D, Locht C.
    Infect Immun; 2001 Oct; 69(10):6038-43. PubMed ID: 11553541
    [Abstract] [Full Text] [Related]

  • 14. Effect of heptakis (2,6-0-dimethyl)beta-cyclodextrin on cell growth and the production of pertussis toxin and filamentous hemagglutinin in Bordetella pertussis.
    Suzuki Y, Imaizumi A, Ginnaga A, Sato H, Sato Y.
    Dev Biol Stand; 1985 Oct; 61():89-92. PubMed ID: 2872134
    [Abstract] [Full Text] [Related]

  • 15. [An observation on immunization reaction and serological effect of adsorbed purified pertussis vaccine].
    Tian X.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Jun; 14(3):155-9. PubMed ID: 8221838
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
    Prince HE, Lapé-Nixon M, Matud J.
    Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
    [Abstract] [Full Text] [Related]

  • 17. The purification and characterization of an acellular pertussis vaccine.
    Chazono M, Yoshida I, Konobe T, Fukai K.
    J Biol Stand; 1988 Apr; 16(2):83-9. PubMed ID: 2897370
    [Abstract] [Full Text] [Related]

  • 18. Aerosol infection test for evaluation of pertussis vaccine.
    Syukuda Y, Watanabe H, Suehara A, Fujii S, Kuno-Sakai H, Kimura M.
    Tokai J Exp Clin Med; 1988 Apr; 13 Suppl():71-7. PubMed ID: 2908529
    [Abstract] [Full Text] [Related]

  • 19. Rapid purification of pertussis toxin (PT) and filamentous hemagglutinin (FHA) by cation-exchange chromatography.
    Ozcengiz E, Kilinç K, Büyüktanir O, Günalp A.
    Vaccine; 2004 Mar 29; 22(11-12):1570-5. PubMed ID: 15063583
    [Abstract] [Full Text] [Related]

  • 20. Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine.
    Auerbach BS, Lake AM, Wilson ME, Willingham FF, Shematek J, Moulton L, Deforest A, Halsey NA.
    Biologicals; 1998 Jun 29; 26(2):145-53. PubMed ID: 9811522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.